Naloxone-insensitive epidural placebo analgesia in a chronic pain patient

Anesthesiology

Volumn 106, Issue 6, 2007, Pages 1239-1242

  Kupers, Ron ^a   Maeyaert, Jan ^b   Boly, Mélanie ^c   Faymonville, Marie Elisabeth ^d   Laureys, Steven ^c  

^a Rigshospitalet   (Denmark)

^b Heilig Hart Ziekenhuis   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTHRODESIS; ARTICLE; CASE REPORT; CHRONIC PAIN; CLINICAL TRIAL; EPIDURAL ANESTHESIA; EPIDURAL CATHETER; HUMAN; LAMINECTOMY; MYELOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; SPINAL CORD COMPRESSION;

ANALGESIA, EPIDURAL; FEMALE; HUMANS; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PLACEBO EFFECT; POSITRON-EMISSION TOMOGRAPHY;

EID: 34249697051     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000265418.68005.8a     Document Type: Article

References (16)

1. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK: Neurobiological mechanisms of the placebo effect. J Neurosci 2005; 25:10390-2
2. Kupers R, Faymonville ME, Laureys S: The cognitive modulation of pain: Hypnosis- and placebo-induced analgesia. Prog Brain Res 2005; 150:251-69
3. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C: Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120:8-15
4. Petrovic P, Kalso E, Petersson KM, Ingvar M: Placebo and opioid analgesia: Imaging a shared neuronal network. Science 2002; 295:1737-40
5. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD: Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004; 303:1162-7
6. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS: Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005; 25:7754-62
7. Rainville P, Duncan GH: Functional brain imaging of placebo analgesia: Methodological challenges and recommendations. Pain 2006; 121:177-80
8. Fields HL, Price DD: Placebo analgesia, Textbook of Pain, 5th edition. Edited by McMahon SB, Koltzenburg M. Philadelphia, Elsevier, 2006, pp 361-7
9. Amanzio M, Benedetti F: Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999; 19:484-94
10. Laureys S, Faymonville ME, Peigneux P, Damas P, Lambermont B, Del Fiore G, Degueldre C, Aerts J, Luxen A, Franck G, Lamy M, Moonen G, Maquet P: Cortical processing of noxious somatosensory stimuli in the persistent vegetative state. Neuroimage 2002; 17:732-41
11. Laureys S, Faymonville ME, Luxen A, Lamy M, Franck G, Maquet P: Restoration of thalamocortical connectivity after recovery from persistent vegetative state. Lancet 2000; 355:1790-1
12. Levine JD, Gordon NC, Fields HL: The mechanism of placebo analgesia. Lancet 1978; 2:654-7
13. Gracely RH, Dubner R, Wolskee PJ, Deeter WR: Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 1983; 306:264-5
14. Vase L, Robinson ME, Verne GN, Price DD: Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005; 115:338-347
15. Price DD, Craggs J, Nicholas Verne G, Perlstein WM, Robinson ME: Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127:63-72
16. Salomons TV, Johnstone T, Backonja MM, Davidson RJ: Perceived controllability modulates the neural response to pain. J Neurosci 2004; 24:199-203